# Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults

> **NCT01993706** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 29 (actual)

## Conditions studied

- HIV Infection
- Monoclonal Antibody, Human
- HIV Antibodies
- VRC01 Monoclonal Antibody
- Neutralizing Antibody

## Interventions

- **DRUG:** VRC-HIVMAB060-00-AB

## Key facts

- **NCT ID:** NCT01993706
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-19
- **Primary completion:** 2015-02-27
- **Final completion:** 2015-02-27
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01993706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01993706, "Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01993706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*